{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:08:21Z","timestamp":1777100901355,"version":"3.51.4"},"reference-count":34,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of L\u2019Aquila","award":["BANDO PSD-MESVA 2022"],"award-info":[{"award-number":["BANDO PSD-MESVA 2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>(1) Background: Uric acid is a well-known cardiovascular (CV) risk factor in the general population but its role in the setting of rheumatic diseases other than gout is unclear. (2) Methods: This is a retrospective study investigating a cohort of 105 pSS patients recording clinical, serological, and CV-related variables including adherence to the Mediterranean diet. (3) Results: We observed a strong relationship between disease activity, interstitial lung disease (ILD), and CV events. The association between ILD and CV events was dependent on higher SUA levels but independent of other traditional CV risk factors. All three cases of previous non-fatal stroke were reported by females aged &lt;65 years, with higher SUA levels, and two of them also had pSS-ILD. Forty (38%) patients had a 10-year risk of fatal and non-fatal CV disease events beyond the cut-off recommended for their age, and using the correction factor of 1.5 currently applied only to rheumatoid arthritis, we could better identify patient subsets characterized by different CV risk profiles including different SUA levels. (4) Conclusions: This study is the first to investigate in depth the role of SUA in the CV scenario of pSS. Our findings underpin the importance of assessing SUA levels in pSS in addition to the other traditional CV risk factors and to consider applying the correction factor for CV risk assessment tools to achieve a better stratification of CV risk.<\/jats:p>","DOI":"10.3390\/nu15071563","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T02:34:54Z","timestamp":1679625294000},"page":"1563","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sj\u00f6gren\u2019s Syndrome: Is Uric Acid the Missing Link?"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1105-5640","authenticated-orcid":false,"given":"Alessia","family":"Alunno","sequence":"first","affiliation":[{"name":"Internal Medicine and Nephrology Division, Department of Life, Health & Environmental Sciences, San Salvatore Hospital, University of L\u2019Aquila, ASL 1 Avezzano-Sulmona-L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1958-5136","authenticated-orcid":false,"given":"Francesco","family":"Carubbi","sequence":"additional","affiliation":[{"name":"Internal Medicine and Nephrology Division, Department of Life, Health & Environmental Sciences, San Salvatore Hospital, University of L\u2019Aquila, ASL 1 Avezzano-Sulmona-L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Maria","family":"Mariani","sequence":"additional","affiliation":[{"name":"Internal Medicine and Nephrology Division, Department of Life, Health & Environmental Sciences, San Salvatore Hospital, University of L\u2019Aquila, ASL 1 Avezzano-Sulmona-L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Martini","sequence":"additional","affiliation":[{"name":"Internal Medicine and Nephrology Division, Department of Life, Health & Environmental Sciences, San Salvatore Hospital, University of L\u2019Aquila, ASL 1 Avezzano-Sulmona-L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Campanozzi","sequence":"additional","affiliation":[{"name":"Internal Medicine and Nephrology Division, Department of Life, Health & Environmental Sciences, San Salvatore Hospital, University of L\u2019Aquila, ASL 1 Avezzano-Sulmona-L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Ferri","sequence":"additional","affiliation":[{"name":"Internal Medicine and Nephrology Division, Department of Life, Health & Environmental Sciences, San Salvatore Hospital, University of L\u2019Aquila, ASL 1 Avezzano-Sulmona-L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jacc.2018.01.006","article-title":"Treating gour in patients with cardiovascular disease: Mutual benefit or unintended consequences?","volume":"71","author":"Givertz","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC Scientific document group. 2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.119.13643","article-title":"Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality over 20 Years","volume":"75","author":"Virdis","year":"2020","journal-title":"Hypertension"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/HJH.0000000000002589","article-title":"Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension Serum uric acid, predicts heart failure in a large Italian cohort: Search for a cut-off value the URic acid Right for heArt Health study","volume":"39","author":"Muiesan","year":"2021","journal-title":"J. Hypertens."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren\u2019s Syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2014.05.015","article-title":"Is minor salivary gland biopsy more than a diagnostic tool in primary Sj\u00f6gren\u2019s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study","volume":"Volume 44","author":"Carubbi","year":"2014","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0961203314554251","article-title":"A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"24","author":"Carubbi","year":"2015","journal-title":"Lupus"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/acr.23821","article-title":"Cardiovascular morbidity and mortality in primary Sj\u00f6gren\u2019s Syndrome: A systematic review and meta-analysis","volume":"72","author":"Beltai","year":"2020","journal-title":"Arthritis Care Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/jch.14541","article-title":"Relationship between serum uric acid and hypertension in patients with primary Sj\u00f6gren\u2019s syndrome: A retrospective cohort study","volume":"24","author":"Luo","year":"2022","journal-title":"J. Clin. Hypertens."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/ard.2009.110619","article-title":"EULAR Sj\u00f6gren\u2019s Task Force. EULAR Sjogren\u2019s syndrome disease activity index: Development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome","volume":"69","author":"Seror","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.2010.143743","article-title":"EULAR Sj\u00f6gren\u2019s Task Force. EULAR Sj\u00f6gren\u2019s Syndrome Patient Reported Index (ESSPRI): Development of a consensus patient index for primary Sj\u00f6gren\u2019s syndrome","volume":"70","author":"Seror","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (US) (2002). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143\u20133421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"ref_17","unstructured":"(2023, January 01). The Interactive Tool for Predicting and Managing the Fatal and Non-Fatal Cardiovascular Disease (CVD) Risk in Individuals without Previous CVD in Europe. Available online: https:\/\/www.heartscore.org\/en_GB\/."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Gonz\u00e1lez, M.A., Garc\u00eda-Arellano, A., Toledo, E., Salas-Salvad\u00f3, J., Buil-Cosiales, P., Corella, D., Covas, M.I., Schr\u00f6der, H., Ar\u00f3s, F., and G\u00f3mez-Gracia, E. (2012). PREDIMED Study Investigators. A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: The PREDIMED trial. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043134"},{"key":"ref_19","first-page":"1153","article-title":"Validation of a questionnaire to measure overall Mediterranean lifestyle habits for research application: The Mediterranean lifestyle index (MEDLIFE)","volume":"32","author":"Bodega","year":"2015","journal-title":"Nutr. Hosp."},{"key":"ref_20","unstructured":"(2022, June 30). CuoreData, Il Progetto Cuore, Istituto Superiore di Sanit\u00e0. Available online: https:\/\/www.cuore.iss.it\/."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/jch.12684","article-title":"Dietary oily fish intake and blood pressure levels: A population-based study","volume":"18","author":"Mera","year":"2016","journal-title":"J. Clin. Hypertens."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/ajh\/hpt231","article-title":"Fish meal supplementation and ambulatory blood pressure in patients with hypertension: Relevance of baseline membrane fatty acid composition","volume":"27","author":"Colussi","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.55563\/clinexprheumatol\/5p5x5p","article-title":"Adherence to the Mediterranean diet and the impact on clinical features in primary Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Carubbi","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/HCO.0000000000000626","article-title":"Hyperuricaemia and vascular risk: The debate continues","volume":"34","author":"Landolfo","year":"2019","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_26","first-page":"546","article-title":"Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sj\u00f6gren\u2019s syndrome","volume":"35","author":"Quartuccio","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1007\/s10753-022-01661-w","article-title":"Serum uric acid as a diagnostic biomarker for rheumatoid arthritis-associated interstitial lung disease","volume":"45","author":"Wang","year":"2022","journal-title":"Inflammation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1164\/rccm.200808-1274OC","article-title":"Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis","volume":"179","author":"Gasse","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"10183","DOI":"10.1038\/s41598-021-89678-3","article-title":"Lung function decline is associated with serum uric acid in Korean health screening individuals","volume":"11","author":"Ahn","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/joim.12346","article-title":"Cardiovascular disease risk burden in primary Sj\u00f6gren\u2019s syndrome: Results of a population-based multicentre cohort study","volume":"278","author":"Bartoloni","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"P400","DOI":"10.1093\/eurheartj\/eht307.P400","article-title":"Primary Sjogren\u2019s syndrome and risk of ischemic stroke: A nationwide study","volume":"34","author":"Chiang","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"674398","DOI":"10.3389\/fneur.2021.674398","article-title":"The relationship between elevated serum uric acid and risk of stroke in adult: An updated and dose-response meta-analysis","volume":"12","author":"Qiao","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Vedder, D., Walrabenstein, W., Heslinga, M., de Vries, R., Nurmohamed, M., van Schaardenburg, D., and Gerritsen, M. (2019). Dietary interventions for gout and effect on the cardiovascular risk factors: A systematic review. Nutrients, 11.","DOI":"10.3390\/nu11122955"},{"key":"ref_34","first-page":"167","article-title":"Unmet needs in primary Sj\u00f6gren\u2019s syndrome and the never-ending quest for the perfect biomarker","volume":"45","author":"Alunno","year":"2020","journal-title":"Acta Reumatol. Port."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/7\/1563\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:01:38Z","timestamp":1760122898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/7\/1563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["nu15071563"],"URL":"https:\/\/doi.org\/10.3390\/nu15071563","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]}}}